Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks

Journal of Geriatric Cardiology

Volumn 9, Issue 1, 2012, Pages 33-37

  Huang, Gang ^a,b   Zhong, Hua ^b   Re, He Man ^c   Mao, Hong Wei ^d   Niu, Qiang ^b   Chi, Ye Hong ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c Hospital of Traditional Chinese Medicine   (China)

^d Youyi Hospital   (China)

Author keywords

ApoAI; ApoB; Coronary heart disease; Gene polymorphism; Kazaks

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84860633446     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2012.00033     Document Type: Article

References (12)

1. Rasouli M, Kiasari AM, Mokhberi V. The ratio of ApoB/ApoAI, ApoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clin Chem Lab Med 2006; 44: 1015-1021. (Pubitemid 44155874)
2. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008; 372: 224-233. (Pubitemid 351978112)
3. Sniderman AD, Kiss RS. The strengths and limitations of the ApoB/ApoAI ratio to predict the risk of vascular disease: a Hegelian analysis. Curr Atheroscler Rep 2007; 9: 261-265. (Pubitemid 350081469)
4. Benn M. Apolipoprotein B levels, ApoB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis 2009; 233: 15.
5. Cheng J, An X, Feng WF, et al. Relationship between lipoprotein(a) (LP(a)) and coronary heart disease in Kazakhstan patients. Chin J Cardiovasc Med 2007; 5: 360-361.
6. Huang G, Xie YJ. Association of apolipoprotein B gene EcoRI, XbaI and apolipoprotein AI gene -75bp and +83bp polymorphisms with coronary heart disease. J Clin Intern Med 2011; 28: 132-135.
7. Benn M, Nordestgaard BG, Jensen JS, et al. Polymorphism in ApoB associated with increased low-density lipoprotein levels in both genders in the general population. J Clin Endocrinol Metab 2005; 90: 5797-5803. (Pubitemid 41415494)
8. Wang LY, Gu Y, Wu GX, et al. A case-control study on the distribution of apolipoprotein AI gene polymorphisms in the survivors of atherosclerosis cerebral infarction. Chin J Epidemiol 2000; 21: 22-25.
9. Zhang AP, Jiang RY, Wu SS. Correlations among ApoB gene's polymorphisms of XbaI and EcoRI loci and coronary heart disease, lipid levels. Chin J of Med Genetic 2002; 19: 435-437.
10. Pan JP, Chiang AN, Tai JJ, et al. Restriction fragment length polymorphisms of Apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem 1995; 41: 424-429.
11. Zou YC, Hu DY, Yang XC, et al. Relationships among ApoAI gene's polymorphisms and lipid levels, coronary heart disease in Chinese. Chin J Arterioscler 2003; 11: 345-348.
12. Yan SK, Li XL, Xue H, et al. Correlations among ApoB gene's polymorphisms of EocRI and MspI loci and coronary heart disease. Chin J Lab Med 2003; 26: 148-152.